Recordati reported EUR231.11M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Almirall EUR 30.23M 12.8M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Orion EUR 114.8M 213.4M Mar/2026
Sanofi EUR 1.94B 239M Mar/2026